TY - JOUR T1 - [Coagulopathy and COVID-19. Recommendations for a changing reality]. AU - Riveros,Dardo, AU - Maymó,Daniela, AU - Laviano,Julia, AU - Fornillo,Florencia Fornillo, AU - Fernández,José, AU - Benzadon,Ricardo, AU - Solimano,Jorge, AU - Cacchione,Roberto, AU - Riera,Leandro, AU - Duarte,Patricio, AU - Cazap,Nicolás, AU - Gotta,Daniel, AU - García Altuve,Juan, AU - Valentini,Ricardo, AU - Dupont,Juan, PY - 2020/10/13/entrez PY - 2020/10/14/pubmed PY - 2020/10/23/medline KW - COVID-19 KW - cytokine storm KW - disseminated intravascular coagulation KW - heparin KW - sepsis induced coagulopathy KW - thromboembolism SP - 505 EP - 511 JF - Medicina JO - Medicina (B Aires) VL - 80 IS - 5 N2 - The coronavirus disease 2019 (COVID-19) pandemic requires rapid medical responses. The risk of venous and arterial thromboembolism increases in critically ill patients with SARS-CoV-2 infection. There is a hypercoagulable state that includes elevated levels of D-dimer, with an increased risk of organ failure and increased mortality. The abnormalities described in hemostasis should be considered for therapeutic decision making. We analyzed the available scientific evidence for the therapeutic approach of coagulopathy in the course of the disease with the objective of designing realistic therapeutic recommendations aimed at reducing morbidity and mortality in patients with COVID-19. SN - 1669-9106 UR - https://www.unboundmedicine.com/medline/citation/33048795/[Coagulopathy_and_COVID_19__Recommendations_for_a_changing_reality]_ DB - PRIME DP - Unbound Medicine ER -